echinacea
purpurea
l
moench
synonym
brauneria
purpurea
l
britton
echinacea
intermedia
lindl
ex
paxton
echinacea
purpurea
var
arkansana
steyerm
echinacea
purpurea
f
liggettii
steyerm
echinacea
purpurea
var
serotina
nutt
lh
bailey
echinacea
serotina
sweet
ex
g
f
echinacea
speciosa
wender
paxton
helichroa
purpurea
l
raf
rudbeckia
purpurea
l
eastern
purpl
conefl
ower
nativ
eastern
north
america
present
extent
wild
much
eastern
southeastern
midwest
unit
state
nativ
temper
rang
occur
open
woodland
thicket
prairi
near
waterway
roadsid
extens
grown
ornament
garden
park
also
cultiv
commerci
herbal
remedi
e
purpurea
thrive
best
full
sun
shade
intoler
fastidi
soil
ph
plant
prefer
loami
sandi
welldrain
soil
also
quit
drought
toler
petal
edibl
dish
includ
echinacea
pane
bagno
bath
bread
decor
fresh
echinacea
petal
wedg
lemon
american
indian
savouri
echinacea
spread
echinacea
melon
fruit
salad
robert
petal
fri
watercress
onion
mustard
leav
spread
sweet
potato
herbac
perenni
cm
high
erect
branch
brownishgreen
glabrou
hairi
stem
plate
fi
brou
root
leav
altern
simpl
lower
leav
broader
ovat
plate
petiol
weakli
wing
petiol
length
decreas
upper
leav
lamina
ovat
lanceol
narrolyl
lanceol
cm
margin
serrat
apex
acut
base
round
acut
flower
head
solitari
stout
termin
peduncl
cm
plate
involucr
bract
linear
lanceol
receptacl
mm
palea
red
orang
tip
slightli
curv
point
disc
conic
subglobos
cm
disc
fl
oret
corolla
greenish
pink
purpl
cm
ray
fl
oret
corolla
pink
purpl
pink
purpl
lamina
spread
recurv
cm
cm
twotooth
apex
spars
hairi
abaxi
plate
cypsela
angl
glabrou
tan
bicolour
dark
brown
distal
band
pappi
persist
mm
promin
teeth
trace
pyrrolizidin
alkaloid
tussilagin
isotussilagin
found
dri
materi
echinacea
angustifolia
e
purpurea
roder
et
al
watersolubl
acid
polysaccharid
methylglucuronoarabinoxylan
isol
hemicellulos
fraction
e
purpurea
character
wagner
et
al
wagner
et
al
proksch
wagner
polysaccharid
contain
link
xylan
backbon
branch
point
three
homogen
polysaccharid
two
neutral
fucogalactoxyloglucan
mean
molecular
weight
acid
arabinogalactan
mean
molecular
weight
isol
medium
echinacea
purpurea
cell
cultur
arabinogalactan
protein
agp
molecular
weight
da
press
juic
echinacea
purpurea
isol
high
molecular
weight
fraction
precipit
yariv
reagent
classen
et
al
compris
high
amount
polysaccharid
ratio
galactos
arabinos
uron
acid
lowprotein
content
high
level
serin
alanin
hydroxyprolin
amino
acid
profi
le
arabinogalactan
protein
compris
serin
alanin
hydroxyprolin
asparagineaspart
acid
threonin
glutamineglutam
acid
arginin
glycin
valin
histidin
lysin
leucin
isoleucin
phenylalanin
monosaccharid
profi
le
arabinogalactan
protein
compris
galactos
arabinos
glucosamin
mannos
rhamnos
molecular
weight
arabinogalactan
protein
agp
press
juic
echinacea
purpurea
found
hydroxyprolin
ww
domin
amino
acid
major
amino
acid
respons
bind
protein
arabinogalactan
subunit
via
glycosid
linkag
volk
et
al
larg
amount
glutamin
glutam
acid
ww
asparagin
aspart
acid
ww
also
found
anoth
arabinogalactan
protein
purifi
ed
e
purpurea
suspens
cultur
classen
compris
high
amount
polysaccharid
ww
domin
monosaccharid
galactos
arabinos
glucuron
acid
small
protein
moieti
ww
main
amino
acid
alanin
hydroxyprolin
serin
glutamineglutam
acid
asparaginesaspart
acid
threonin
polysaccharid
part
compos
branch
corepolysaccharid
galp
residu
termin
araf
arap
galp
glcap
residu
compar
arabinogalactan
protein
press
juic
aerial
part
echinacea
purpurea
differ
particularli
termin
arabinos
monoand
oligosaccharid
arabinogalactan
ag
side
branch
could
detect
two
group
miner
fe
cu
mn
li
ii
ca
mg
zn
ni
identifi
ed
aerial
part
root
e
purpurea
serbia
et
al
trace
element
profi
le
root
stem
leav
fl
ower
found
differ
signifi
cantli
aerial
part
echinacea
purpurea
afford
addit
known
compound
fi
highli
unsatur
acetylen
amid
deriv
linolen
bohlmann
hoffmann
aerial
part
e
purpurea
found
contain
differ
structur
type
alkamid
root
yield
similar
alkamid
pattern
bauer
reming
alkamid
level
differ
signifi
cantli
among
root
rhizom
stem
leav
fl
ower
e
purpurea
perri
et
al
root
distinguish
plant
part
higher
level
dienediyn
alkamid
wherea
level
tetraen
alkamid
dienediyn
highest
veget
stem
ratio
stereoisomer
tetraen
alkamid
differ
fl
ower
e
purpurea
part
alkylamid
cichor
acid
dri
root
aerial
part
e
purpurea
grown
eastern
australia
determin
follow
total
alkylamid
concentr
root
sampl
mgg
rang
mgg
aerial
sampl
mgg
rang
mgg
will
stuart
cichor
acid
concentr
root
sampl
mgg
rang
mgg
aerial
sampl
mgg
rang
mgg
stuart
will
found
total
alkamid
concentr
e
purpurea
root
stem
leaf
decreas
throughout
fi
rst
grow
season
concentr
fl
ower
increas
matur
plant
root
contain
total
plant
alkamid
approxim
fl
ower
stem
leaf
tissu
rel
proport
individu
alkamid
root
chang
plant
growth
cichor
acid
concentr
plant
tissu
decreas
plant
senesc
similar
concentr
cichor
acid
measur
root
fl
ower
leaf
tissu
stem
level
lower
matur
plant
fl
ower
leaf
contain
total
plant
cichor
acid
root
stem
contain
approxim
respect
cichor
acid
main
phenol
e
purpurea
root
mean
summer
autumn
top
summer
autumn
follow
caftar
acid
main
phenol
compound
root
summer
autumn
top
summer
autumn
perri
et
al
autumngrown
echinacea
purpurea
plant
taiwan
produc
caffeoyl
phenol
particularli
cichor
acid
caftar
acid
leaf
fl
ower
tissu
springgrown
plant
chen
et
al
iranian
cultiv
e
purpurea
top
found
high
content
cichor
acid
follow
caftar
acid
caffeic
acid
total
polyphenol
content
iranshahi
amanzadeh
hour
boil
water
extract
content
cichor
acid
wherea
content
acid
ethanolwat
extract
exceed
total
alkamid
concentr
mgg
dri
weight
basi
among
individu
e
purpurea
plant
vari
mean
root
mean
nearli
matur
seed
head
mean
young
top
fl
ower
head
leav
stem
qu
et
al
cichor
acid
concentr
among
individu
plant
vari
mean
mean
mean
root
seed
head
top
respect
e
e
z
e
tetraeno
acid
isobutylamid
e
e
z
z
tetraeno
acid
isobutylamid
alkamid
account
total
alkamid
root
compris
seed
head
young
top
two
cinnam
acid
isoferuloyltartar
isoferuloyltartar
acid
along
three
known
caffeic
acid
cichor
acid
feruloyltartar
acid
coumaroyltartar
acid
isol
purifi
ed
echinacea
purpurea
mg
crude
extract
mg
mg
mg
mg
mg
isol
puriti
respect
nineteen
phenol
identifi
ed
medium
e
purpurea
cell
cultur
elicit
biotic
elicitor
barz
medium
contain
lignan
neolignan
acetophenon
deriv
main
elicitorenhanc
product
e
purpurea
cell
mainli
contain
phenol
glycosid
includ
new
compound
glucopyranosylacetovanillon
constitut
compound
identifi
ed
cell
cultur
medium
e
purpurea
includ
coniferyl
alcohol
methyl
e
p
coumar
elicit
e
purpurea
cell
cultur
yeast
compound
found
medium
includ
yacetosyringon
e
phenoxi
b
buddlenol
b
phenol
found
e
purpurea
cell
scopoletin
acid
glucos
ester
e
phenoxi
b
longilorosid
optima
accumul
echinacea
purpurea
suspens
cultur
biomass
gl
fw
gl
dw
phenol
mgg
dw
fl
avonoid
mgg
dw
achiev
ms
murashig
skoog
medium
wu
et
al
high
adventiti
root
biomass
gl
fw
gl
dw
achiev
feed
ms
medium
end
week
led
slight
decreas
total
product
phenol
fl
avonoid
howev
feed
respons
increas
accumul
caftar
acid
mgg
dw
cichor
acid
mgg
dw
besid
mani
studi
isol
identifi
ed
alkamid
caffeic
acid
deriv
e
pur
purea
plant
variou
plant
part
product
laasonen
et
al
et
al
ultrason
extract
dri
sampl
e
purpurea
root
aerial
part
methanolwat
ethanolwat
gave
good
yield
cichor
acid
echinacosid
alkamid
e
z
acid
isobutylamid
mixtur
e
e
z
ez
tetraeno
acid
isobutylamid
recoveri
respect
hplc
separ
phenol
compound
cichor
acid
chlorogen
acid
echinacosid
also
improv
care
attent
ph
mobil
phase
profi
le
phenol
compound
mean
concentr
e
purpurea
herb
determin
caftar
acid
chlorogen
acid
caffeic
acid
cynarin
cichor
acid
echinacosid
tet
e
e
z
e
ztetraeno
acid
isobutylamid
studi
show
content
caffeic
acid
deriv
e
purpurea
aerial
part
root
reach
highest
middl
stage
full
blossom
liu
et
al
content
caffeic
acid
deriv
fresh
raw
materi
gener
higher
dri
raw
materi
development
pattern
total
phenol
e
purpurea
caffeic
acid
deriv
stage
midbloom
optim
harvest
period
caffeic
acid
deriv
total
phenol
signifi
cant
differ
content
caffeic
acid
deriv
among
three
chines
geograph
popul
e
purpurea
e
purpurea
extract
store
month
found
contain
caftar
acid
cichor
acid
z
e
acid
isobutylamid
concentr
mg
ml
respect
use
hplc
electrospray
ioniz
mass
spectrometri
isomer
isobutylamid
could
distinguish
cichor
acid
main
phenol
compound
detect
dri
e
purpurea
materi
fl
ower
leav
stem
root
follow
caftar
acid
lin
et
al
bioactiv
constitu
content
differ
plant
part
descend
order
fl
ower
leav
stem
root
caffeic
acid
deriv
total
phenol
content
affect
dri
method
storagepack
condit
cool
winddri
materi
retain
bioactiv
constitu
content
compar
vacuum
freezedri
materi
storabl
result
indic
freezedri
e
purpurea
materi
seal
polyethylen
terephthalatealuminium
foilpolyethylen
nylonpolyethylen
bag
store
rel
humid
without
light
condit
retain
highest
content
bioactiv
compound
volatil
headspac
e
purpurea
fl
ower
acetaldehyd
dimethyl
sulphid
aceton
unknown
camphen
hexan
sabinen
unknown
limonen
tran
ocimen
tran
ocimen
p
cymen
unknown
allo
ocimen
ci
tran
mazza
cottrel
major
volatil
headspac
fl
ower
tissu
myrcen
dimethyl
sulphid
essenti
oil
e
purpurea
fl
ower
head
found
contain
compon
monoterpen
hydrocarbon
oxygen
monoterpen
sesquiterpen
oxygen
sesquiterpen
identifi
ed
compris
total
oil
yield
diraz
et
al
major
compon
germacren
caryophyllen
oxid
compon
higher
includ
p
cymen
acadinen
naphthalen
sci
ene
naphthalen
bicylo
decaton
ethyl
oleat
vulgarol
b
aromadendren
oxid
difl
isoaromadendien
epoxid
tran
z
epoxid
benzenepropano
acid
octadecyl
ester
epoxid
earlier
compound
compris
sesquiterpen
monoterpen
hydrocarbon
identifi
ed
e
purpurea
fl
owerhead
essenti
oil
iran
mirjalili
et
al
germacren
major
compon
rutin
nicotifl
orin
rutinosid
campherol
isol
fl
ower
latter
fl
avonoid
domin
kurkin
et
al
major
anthocyanin
echinacea
purpurea
e
pallida
identifi
ed
cyanidin
glucopyranosid
cyanidin
glucopyranosid
cheminat
et
al
cyanidin
glucopyranosid
mg
cyanidin
glucopyranosid
mg
obtain
mg
crude
fl
ower
extract
puriti
respect
profi
le
phenol
compound
mean
concentr
e
purpurea
fl
ower
determin
caftar
acid
chlorogen
acid
caffeic
acid
cynarin
cichor
acid
echinacosid
tet
e
e
z
e
ztetraeno
acid
isobutylamid
echinacea
purpurea
cultivar
magnu
white
swan
line
harvest
dri
fl
ower
head
contain
highest
cichor
acid
content
follow
caftar
acid
chlorogen
acid
content
cynarin
echinacosid
fl
ower
head
rel
low
compar
cichor
acid
caftar
acid
chlorogen
acid
total
caffeoyl
deriv
content
mgg
dri
weight
line
magnu
white
swan
respect
alkamid
e
e
z
e
tetraeno
acid
isobutylamid
alkamid
e
e
z
ztetraeno
acid
isobutylamid
alkamid
also
found
fl
ower
head
content
much
lower
root
statist
signifi
cant
differ
fl
owerhead
alkamid
content
found
among
test
e
purpurea
cultivar
line
extract
yield
phenol
freezedri
e
purpurea
fl
ower
signifi
cantli
affect
ethanol
concentr
water
extract
give
highest
extract
yield
tsai
et
al
ethanol
volum
percentag
solvent
increas
extract
yield
decreas
water
extract
yield
mgg
extract
caftar
acid
mg
chlorogen
acid
mg
echinosid
mg
cichor
acid
total
caffeic
acid
deriv
content
cichor
acid
caftar
acid
dri
e
purpurea
fl
ower
found
signifi
cantli
affect
dri
method
use
kim
et
al
although
signifi
cant
loss
cichor
acid
observ
fl
ower
store
high
moistur
vacuum
microwavedri
fl
ower
lowmoistur
content
retain
highest
level
cichor
acid
caftar
acid
similar
freezedri
fl
ower
flower
airdri
retain
airdri
lowest
retent
acid
although
fl
ower
airdri
retain
rel
high
amount
cichor
acid
caftar
acid
time
hour
requir
reach
optim
dri
consider
longer
minut
vacuum
microwav
dri
also
found
individu
alkamid
concentr
root
leav
affect
dri
method
use
kim
et
al
preserv
higher
level
total
alkamid
freezedri
found
best
method
vacuum
microwav
dri
superior
method
dri
root
airdri
airdri
prefer
method
dri
leav
e
purpurea
two
major
alkamid
peak
identifi
ed
e
purpurea
achen
e
z
acid
isobutylamid
e
e
e
e
z
tetraeno
acid
isobutylamid
et
al
isom
pair
tetraen
purifi
ed
standard
quantifi
cation
alkamid
content
e
purpurea
achen
root
seed
oil
yield
e
angustifolia
e
pallida
e
purpurea
harvest
rang
oomah
et
al
vitamin
e
content
oil
rang
g
oil
constitut
total
tocopherol
oil
highli
polyunsatur
abund
linol
oleic
palmit
acid
togeth
compris
total
fatti
acid
e
purpurea
seed
oil
contain
linol
oleic
palmit
acid
year
harvest
linol
oleic
palmit
acid
harvest
fruit
achen
e
purpurea
found
contain
light
yellow
fatti
oil
compris
unsatur
fatti
acid
satur
fatti
acid
major
compon
linol
acid
oleic
acid
equival
iodin
number
vandyshev
et
al
eighteen
compon
identifi
e
purpurea
seed
oil
compris
total
area
petroleum
ether
solvent
solvent
n
hexan
solvent
diraz
et
al
abund
fatti
acid
palmit
acid
stearic
acid
oleic
acid
linol
acid
fatti
acid
profi
le
use
petroleum
ether
n
hexan
solvent
respect
follow
oleic
acid
palmit
acid
linol
acid
oxocol
myrist
acid
pentadecano
acid
palmitol
acid
carbon
acid
heptadecano
acid
stearic
acid
elaid
acid
linolelaid
acid
arachid
acid
gammalinolen
acid
eicoseno
acid
behen
acid
tricosano
acid
lignocer
acid
oxiraneoctano
acid
oxocol
heptadeceno
acid
elaid
acid
linolelaid
acid
could
defi
ned
solvent
n
hexan
volatil
headspac
e
purpurea
leaf
tissu
acetaldehyd
dimethyl
sulphid
propan
pentanl
camphen
hexan
sabinen
pentan
limonen
ci
tran
ocimen
tran
ocimen
p
cymen
hexyl
acet
allo
ocimen
ci
tran
caryophyllen
germacren
h
furanon
hexan
mazza
cottrel
major
volatil
headspac
leaf
tissu
myrcen
dimethyl
sulphid
total
phenol
content
report
e
purpurea
leaf
mg
g
dw
et
al
major
phenol
compound
g
dw
found
phenol
acid
mg
caffeic
acid
mg
neochlorogen
acid
mg
p
coumar
acid
mg
ferul
acid
fl
avonoid
mg
quercetin
echinacea
purpurea
cultivar
magnu
white
swan
line
harvest
dri
leav
contain
highest
cichor
acid
content
follow
caftar
acid
echinacosid
content
chlorogen
acid
cynarin
leav
rel
low
compar
cichor
acid
caftar
acid
chlorogen
acid
among
fi
caffeoyl
deriv
examin
leav
greater
cichor
acid
caftar
acid
cynarin
echinacosid
level
magnu
white
swan
total
caffeoyl
deriv
content
mgg
dri
weight
line
cultivar
magnu
cultivar
white
swan
respect
line
highest
e
e
z
e
tetraeno
acid
isobutylamid
alkamid
e
e
z
ztetraeno
acid
isobutylamid
alkamid
content
dri
leav
among
test
cultivar
line
profi
le
phenol
compound
mean
concentr
e
purpurea
leaf
stem
determin
caftar
acid
chlorogen
acid
caffeic
acid
cynarin
cichor
acid
echinacosid
tet
e
e
z
e
z
tetraeno
acid
isobutylamid
volatil
headspac
e
purpurea
stem
tissu
acetaldehyd
dimethyl
sulphid
aceton
geranyl
acet
camphen
hexan
sabinen
unknown
limonen
tran
ocimen
tran
ocimen
allo
ocimen
ci
tran
germacren
mazza
cottrel
major
volatil
headspac
stem
tissu
myrcen
dimethyl
sulphid
volatil
headspac
e
purpurea
root
acetaldehyd
dimethyl
sulphid
aceton
ethanol
acet
trichloroacet
acid
camphen
hexan
sabinen
heptan
limonen
ocimen
p
cymen
hexyl
acet
unknown
benzaldehyd
mazza
cottrel
major
volatil
headspac
root
tissu
dimethyl
sulphid
seventeen
lipophil
volatil
semivolatil
compon
includ
alkamid
known
e
purpurea
root
identifi
ed
cucumb
mosaic
cucumoviru
infect
found
respons
signifi
cant
variat
rel
composit
major
constitu
particular
germacren
dodeca
root
extract
e
purpurea
root
found
contain
chlorogen
acid
caftar
acid
cafeic
acid
trace
cichor
acid
alkamid
undeca
e
acid
isobutylamid
bauer
et
al
bauer
reming
binn
et
al
perri
et
al
hall
senchina
et
al
pietta
et
al
gotti
et
al
pomponio
et
al
solco
cynarin
echinacosid
detect
root
five
alkylamid
e
z
acid
isobutylamid
e
z
acid
isobutylamid
e
e
e
acid
isobutylamid
e
e
z
trienoic
acid
isobutylamid
e
z
acid
isol
root
bauer
et
al
nine
alkamid
identifi
ed
root
e
purpurea
et
al
similar
fi
ngerprint
report
bauer
remig
sever
minor
alkamid
also
tent
identifi
ed
follow
alkamid
identifi
ed
fresh
dri
root
extract
e
purpurea
spelman
et
al
e
z
acid
isobutylamid
p
e
acid
q
acid
r
quantiti
isomer
alkylamid
k
l
alkylamid
j
ethanol
extract
e
purpurea
root
determin
term
concentr
isomer
tetraen
compound
k
l
e
acid
isobutylamid
compound
j
per
ml
solvent
three
differ
echinacea
root
extract
fresh
dri
dri
contain
alkylamid
howev
dri
extract
contain
greatest
amount
compound
three
extract
techniqu
investig
fresh
dri
dri
result
similar
alkylamid
profi
le
gave
similar
yield
alkylamid
total
dissolv
solid
similar
alkylamid
content
fresh
dri
extract
indic
dri
root
materi
result
loss
alkylamid
conclud
either
fresh
dri
root
could
use
prepar
extract
high
alkylamid
content
although
overal
yield
slightli
lower
fresh
extract
caffeic
acid
deriv
caftar
acid
chlorogen
acid
caffeic
acid
cichor
acid
alka
detect
root
extract
luo
et
al
three
alkamid
nitidanin
diisovalerian
identifi
ed
togeth
known
alkamid
one
sesquiterpen
root
echinacea
purpurea
hohmann
et
al
cichor
acid
verbascosid
predomin
extract
e
purpurea
root
sloley
et
al
total
alkamid
three
ketoalken
two
ketoalkyn
four
phenol
acid
echinacosid
cichor
acid
caftar
acid
chlorogen
acid
identifi
ed
aqueou
ethanol
root
extract
echinacea
purpurea
echinacea
pallida
thomsen
et
al
major
alkamid
root
e
purpurea
lowest
concentr
middl
autumn
earli
winter
major
phenol
acid
highest
concentr
spring
e
purpurea
root
extract
major
alkamid
e
e
z
e
ztetraeno
acid
isobutyl
amid
significantli
affect
storag
temperatur
cichor
acid
content
declin
signifi
cantli
compar
lowtemperatur
storag
livesey
et
al
root
powder
major
alkamid
show
signifi
cantli
reduc
level
cichor
acid
declin
signifi
cantli
biomass
accumul
product
caffeic
acid
deriv
caftar
acid
chlorogen
acid
cichor
acid
echinacea
purpurea
adventiti
root
cultur
optim
incub
temperatur
among
differ
incub
temperatur
test
wu
et
al
biomass
adventiti
root
highest
cultur
grown
dark
accumul
caffeic
acid
deriv
optimum
cultur
grown
hour
light
dark
cultur
regim
studi
found
hairi
root
cultur
stimul
everi
day
ultrasound
minut
produc
highest
amount
caffeic
acid
deriv
cad
day
cultur
among
ultrasound
treatment
experi
obviou
increas
cad
product
e
purpurea
hairi
root
stimul
ultrasound
relat
increas
rolbregul
endogen
acid
biosynthesi
phenylalanin
ammonium
lyas
pal
activ
echinacea
purpurea
cultivar
magnu
white
swan
line
harvest
dri
root
contain
highest
cichor
acid
content
follow
caftar
acid
cynarin
echinacosid
chlorogen
acid
caffeoyl
deriv
mgg
dri
weight
magnu
white
swan
respect
compar
fl
ower
leav
root
contain
highest
content
alkamid
e
e
z
e
tetraeno
acid
isobutylamid
alkamid
e
e
z
z
tetraeno
acid
isobutylamid
alkamid
white
swan
accumul
consider
higher
alkamid
content
dri
root
magnum
line
highli
watersolubl
fructan
isol
e
purpurea
root
wack
blaschek
fructan
repres
linear
inulintyp
fructan
almost
exclus
link
fructosyl
unit
termin
glucos
termin
fructos
small
proport
link
branch
point
residu
detect
ethanolinsolubl
fructan
e
purpurea
show
averag
mean
degre
polymer
ethanolinsolubl
fructan
ethanolinsolubl
fructan
commerci
echinacea
extract
manufactur
primarili
three
echinacea
speci
name
echinacea
purpurea
herb
root
seed
e
angustifolia
root
e
pallida
root
mahadi
et
al
current
recommend
use
product
includ
oral
administr
prophylaxi
treatment
common
cold
bronchiti
infl
uenza
bacteri
viral
infect
respiratori
tract
howev
base
exist
data
product
contain
press
juic
hydroalcohol
extract
echinacea
purpurea
leaf
juic
root
e
pallida
root
convinc
data
support
use
accord
spelman
et
al
echinacea
purpurea
topsel
botan
medicin
current
consider
interest
due
immunomodulatori
antiinfl
ammatori
antivir
cannabinoid
receptor
cb
bind
activ
alkylamid
constitu
immunostimul
drug
contain
multipl
bioactiv
substanc
polysaccharid
caffeic
acid
deriv
caffeic
acid
cichor
acid
caftar
acid
chlorogen
acid
alkamid
glycoprotein
kreft
among
mani
pharmacolog
properti
report
e
purpurea
extract
immunomodul
macrophag
demonstr
convincingli
barrett
sever
dozen
clinic
studiesinclud
number
blind
random
trialshad
report
health
benefi
ts
robust
data
studi
test
e
purpurea
extract
treatment
acut
upper
respiratori
infect
although
indic
modest
benefi
studi
limit
size
methodolog
qualiti
although
great
deal
moder
goodqual
scientifi
c
data
regard
e
purpurea
effect
treat
ill
enhanc
human
health
exist
much
yet
proven
beyond
reason
doubt
numer
studi
shown
e
purpurea
exhibit
immunostimul
antimicrobi
antiinflammatori
antioxid
cytochrom
enzym
inhibitori
antiandrogen
cannabinoidomimet
radioprotect
antitumor
activ
gupta
et
al
mechan
antioxid
activ
extract
deriv
e
angustifolia
e
pallida
e
purpurea
root
includ
free
radic
scaveng
transit
metal
chelat
hu
kitt
root
extract
echinacea
spp
capabl
scaveng
hydroxyl
dpph
abt
radic
root
extract
delay
format
conjug
dien
hydroperoxid
induc
thermal
decomposit
dihydrochlorid
protract
lag
phase
peroxid
soybean
liposom
root
extract
also
suppress
oxid
human
lowdens
lipoprotein
evalu
reduc
agaros
electrophoret
mobil
follow
oxid
modifi
cation
cu
studi
show
e
purpurea
extract
antioxid
activ
similar
ascorb
acid
seriou
effect
inhibit
chicken
peripher
blood
mononuclear
cell
viabil
lee
et
al
hydrazyl
radic
dpph
scaveng
capac
ed
extract
measur
mgml
superoxid
anion
scaveng
capac
extract
nearli
equival
ascorb
acid
vs
concentr
mgml
ed
mgml
respect
reduc
power
extract
increas
linearli
concentr
concentr
mgml
reach
ascorb
acid
mgml
chelat
capac
ferrou
iron
fe
good
synthet
metal
chelat
edta
ad
mgml
e
purpurea
extract
polysaccharid
content
extract
mgg
dri
weight
dw
total
phenol
compound
mg
gallic
acid
equivalentg
dw
microcultur
tetrazolium
assay
show
extract
cell
viabil
mgml
chicken
peripher
blood
mononuclear
cell
pbmc
raw
macrophag
neither
reach
ic
level
extract
root
leav
e
purpurea
found
antioxid
properti
freerad
scaveng
assay
lipid
peroxid
assay
sloley
et
al
methanol
root
extract
e
purpurea
e
pallida
e
angustifolia
exhibit
dpph
antioxid
activ
ec
valu
ml
respect
pellati
et
al
radic
scaveng
activ
echinacea
root
extract
refl
ect
phenol
content
total
phenol
content
mgg
e
purpurea
mgg
e
pallida
mgg
e
angustifolia
caftar
acid
chlorogen
acid
caffeic
acid
cynarin
echinacosid
cichor
acid
identifi
ed
quantifi
ed
echinacea
root
deriv
pure
echinacosid
highest
capac
quench
dpph
radic
ec
caftar
acid
lowest
ec
antioxid
activ
three
extract
one
alkamid
fraction
four
polysaccharidecontain
fraction
three
caffeic
acid
deriv
echinacea
purpurea
root
evalu
measur
inhibit
invitro
cu
ii
catalyz
oxid
human
lowdens
lipoprotein
ldl
dalbybrown
et
al
among
extract
aqueou
ethanol
extract
exhibit
ten
time
longer
lag
phase
prolong
lpp
ethanol
extract
turn
exhibit
longer
lpp
water
extract
antioxid
activ
test
echinacea
extract
fraction
isol
compound
dose
depend
synergist
antioxid
effect
echinacea
constitu
found
cichor
acid
major
caffeic
acid
deriv
e
purpurea
echinacosid
major
caffeic
acid
deriv
echinacea
pallida
echinacea
angustifolia
combin
natur
mixtur
alkamid
andor
water
extract
contain
high
molecular
weight
compound
extract
stem
leav
root
echinacea
purpur
constitu
cichor
acid
found
effi
cient
scaveng
dpph
radic
activ
compar
rosmarin
acid
wellcharacter
antioxid
thygesen
et
al
effi
caci
extract
reaction
dpph
correl
well
amount
cichor
acid
present
variou
extract
alkamid
alon
show
antioxid
activ
test
alkamid
present
extract
increas
howev
antioxid
effect
cichor
acid
peroxid
lipid
emuls
assay
antioxid
activ
term
teac
g
dw
e
purpurea
leav
report
abt
dpph
frap
ferric
reduc
antioxid
power
assay
et
al
total
phenol
content
report
mg
g
dw
dpph
scaveng
reach
valu
ec
extract
obtain
classic
ultrasound
extract
respect
et
al
level
scaveng
abil
test
sampl
dpph
radic
descend
order
ascorb
acid
bha
butyl
hydroxyanisol
fl
ower
extract
tsai
et
al
level
ml
fl
ower
extract
show
scaveng
abil
respect
radic
scaveng
abil
e
purpurea
fl
ower
extract
could
attribut
caffeic
acid
deriv
especi
cichor
acid
two
adjac
hydroxyl
group
phenol
ring
show
highest
radic
scaveng
abil
order
potenc
dpph
radic
follow
echinacosid
cichor
acid
chlorogen
acid
caffeic
acid
caftar
acid
level
reduc
power
sampl
descend
order
ascorb
acid
bha
fl
ower
extract
ascorb
acid
bha
fl
ower
extract
attain
maximum
reduc
power
au
respect
fl
ower
extract
exert
ferrou
ion
chelat
effect
mgml
concentr
compar
edta
ethylenediaminetetraacet
acid
concentr
studi
found
main
immunostimulatori
activ
echinacea
resid
watersolubl
materi
rather
lipoid
small
molecul
pillai
et
al
use
fl
ow
cytometri
demonstr
link
polysaccharid
echinacea
biolog
immunostimulatori
effect
e
purpurea
e
pallida
e
angustifolia
leav
stem
fl
ower
top
root
produc
substanti
immunostimulatori
activ
invitro
invivo
studi
indic
therapeut
effect
echinacea
due
stimul
cellular
immun
respons
mahadi
et
al
purifi
ed
polysaccharid
ep
prepar
echinacea
purpurea
shown
strongli
activ
macrophag
develop
pronounc
extracellular
cytotox
tumour
target
stimpel
et
al
splenic
lymphocyt
mice
treat
e
purpurea
hypericum
perforatum
two
dose
level
use
mgkgday
shown
significantli
resist
apoptosi
mice
treat
vehicl
di
carlo
et
al
mice
treat
natur
substanc
show
decreas
fasag
express
increas
express
methylglucuronoarabinoxylan
isol
e
purpurea
show
immunestimul
activ
sever
invitro
immunolog
test
system
wagner
et
al
proksch
wagner
fucogalactoxyloglucan
mean
molecular
weight
isol
e
purpurea
cell
cultur
enhanc
phagocytosi
vitro
invivo
arabinogalactan
specifi
calli
stimul
macrophag
excret
tumour
necrosi
factor
tnf
arabinogalactan
protein
agp
press
juic
aerial
part
echinacea
purpurea
demonstr
bind
lymphocyt
monocyt
granulocyt
differ
donor
thude
et
al
high
molecular
weight
arabinogalactan
protein
agp
press
juic
echinacea
purpurea
known
exhibit
immunomodulatori
properti
vitro
character
volk
et
al
normal
human
peripher
blood
macrophag
cultur
concentr
echinacea
purpurea
fresh
press
juic
low
produc
significantli
higher
level
unstimul
cell
burger
et
al
high
level
induc
low
level
echinacea
consist
immuneactiv
antivir
effect
echinacea
induc
lower
level
comparison
cytokin
measur
echinacea
herb
root
powder
found
stimul
murin
macrophag
cytokin
secret
well
signifi
cantli
enhanc
viabil
andor
prolifer
human
peripher
blood
mononuclear
cell
vitro
rining
et
al
contrast
echinacea
extract
chemic
standard
phenol
acid
echinacosid
content
fresh
press
juic
prepar
found
inact
immunostimulatori
agent
display
vari
degre
antiinfl
ammatori
antioxid
properti
studi
show
e
purpurea
root
leafstem
extract
exhibit
opposit
enhanc
vs
inhibitori
modulatori
effect
express
marker
human
dendrit
cell
dc
wang
et
al
downregul
mrna
express
specifi
c
chemokin
eg
receptor
eg
observ
stemand
leaftreat
dc
chemokin
regulatori
molecul
eg
involv
cjun
pathway
found
upregul
roottreat
dc
anoth
studi
follow
hour
exposur
dendrit
cell
mice
e
purpurea
root
leaf
extract
found
polysacchariderich
root
extract
increas
express
mhc
class
ii
surfac
biomark
wherea
alkylamiderich
leaf
extract
inhibit
express
molecul
benson
et
al
product
increas
concentrationdepend
manner
exposur
root
leaf
extract
contrast
leaf
root
extract
inhibit
enzymat
activ
leaf
root
extract
inhibit
antigenspecifi
c
activ
cell
ot
mice
result
suggest
e
purpurea
could
immunostimulatori
immunosuppress
andor
antiinfl
ammatori
depend
plant
part
extract
method
e
purpurea
extract
solvent
mixtur
ethanolwat
dosedepend
inhibit
interleukin
product
human
jurkat
cell
sasagawa
et
al
inhibitori
activ
correl
presenc
alkylamid
caffeic
acid
deriv
e
purpurea
extract
suppress
cytotox
lower
concentr
signifi
cantli
decreas
product
cell
viabil
alkylamid
concentr
found
extract
decreas
product
approxim
cell
viabil
dosedepend
manner
echinacea
sever
phytochem
compon
found
oppos
effect
express
jurkat
cell
human
tcell
line
matthia
et
al
absenc
stimul
echinacea
compon
exert
signifi
cant
effect
basal
express
level
presenc
endotoxin
lp
express
decreas
howev
decreas
signifi
cantli
revers
treatment
cichor
acid
echinacea
root
extract
prepar
echinacea
angustifolia
echinacea
purpurea
alkylamid
fraction
deriv
combin
phorbol
myrist
acet
stimul
jurkat
cell
effect
express
mix
depend
concentr
cichor
acid
alkylamid
significantli
induc
level
wherea
alkylamid
caus
signifi
cant
inhibit
contrast
echinacea
mix
alkylamid
fraction
exert
effect
pugh
et
al
found
differ
total
bacteri
load
within
echinacea
purpurea
sampl
strongli
correl
invitro
macrophag
activ
activ
cell
content
bacteri
lipopolysaccharid
extract
result
ad
grow
bodi
evid
bacteria
within
echinacea
main
sourc
compon
respons
enhanc
innat
immun
function
polysaccharid
purifi
ed
largescal
echinacea
purpurea
plant
cell
cultur
found
activ
human
phagocyt
vitro
vivo
induc
acutephas
c
reaction
roesler
et
al
substanc
enhanc
spontan
motil
polymorphonuclear
leukocyt
pmn
soft
agar
increas
abil
cell
kill
staphylococci
monocyt
activ
secret
tumour
necrosi
factor
alpha
interleukin
wherea
class
ii
express
unaffect
intraven
applic
polysaccharid
test
subject
immedi
induc
fall
number
pmn
peripher
blood
indic
activ
adher
endotheli
cell
declin
follow
leukocytosi
due
increas
number
pmn
lesser
increas
monocyt
acutephas
creactiv
protein
crp
induc
probabl
due
activ
monocyt
macrophag
produc
subsequ
invivo
studi
found
purifi
ed
polysaccharid
ep
echinacea
purpurea
plant
cell
cultur
enhanc
mice
phagocyt
activ
thu
protect
system
infect
listeria
monocytogen
candida
albican
roesler
et
al
confi
rmed
hypothesi
macrophag
differ
organ
origin
could
activ
produc
produc
elev
amount
reactiv
oxygen
intermedi
inhibit
growth
candida
albican
invitro
invivo
substanc
could
induc
increas
prolifer
phagocyt
spleen
bone
marrow
migrat
granulocyt
peripher
blood
subsequ
studi
ep
found
effect
activ
periton
macrophag
isol
anim
administr
cyclophosphamid
cp
cyclosporin
csa
et
al
eptreat
macrophag
exhibit
increas
product
tumour
necrosi
factoralpha
tnf
enhanc
cytotox
tumour
target
wehi
well
intracellular
parasit
leishmania
enrietti
cpmediat
reduct
leukocyt
peripher
blood
polysaccharid
induc
earlier
infl
ux
neutrophil
granulocyt
compar
pb
phosphat
buffer
salin
treat
control
ep
treatment
mice
immunosuppress
cp
csa
restor
resist
lethal
infect
predominantli
macrophagedepend
pathogen
listeria
monocytogen
predominantli
granulocytedepend
candida
albican
result
studi
suggest
oral
gavag
echinacea
prepar
contain
optim
concentr
cichor
acid
polysaccharid
alkylamid
potenti
effect
stimul
invivo
nonspecifi
c
immun
respons
normal
male
spraguedawley
rat
goel
et
al
b
among
compon
alkylamid
dose
level
bodi
weightday
signifi
cantli
increas
phagocyt
activ
well
phagocyt
index
alveolar
macrophag
alveolar
macrophag
obtain
alkylamideadminist
group
also
produc
signifi
cantli
nitric
oxid
invitro
stimul
lp
activ
compon
control
immunomodulatori
effect
alkylamid
appear
pronounc
lung
spleen
studi
demonstr
echinacea
purpurea
extract
potent
activ
natur
killer
nk
cell
cytotox
gan
et
al
nk
cytotox
augment
concentr
echinacea
short
time
assay
echinacea
augment
frequenc
nk
target
conjug
activ
program
lysi
nk
cell
anoth
studi
dietari
administr
e
purpurea
day
age
normal
mice
thyroxin
inject
reveal
e
purpurea
thyroxin
capac
increas
natur
killer
nk
cell
number
age
mice
refl
ect
increas
new
nk
cell
product
bone
marrow
gener
site
lead
increas
absolut
number
nk
cell
spleen
primari
destini
currier
miller
e
purpurea
mediat
increas
nk
cell
number
also
parallel
increas
antitumour
cytolyt
function
capac
recent
studi
levamisol
echinacea
purpurea
separ
togeth
exert
stimul
effect
immun
system
rat
sadigheteghad
et
al
gamma
globulin
level
white
blood
cell
neutrophil
monocyt
count
phagocyt
activ
increas
significantli
comparison
normal
salin
group
studi
group
receiv
echinacea
levamisol
simultan
effect
synergist
increas
male
rat
oral
treat
two
differ
dose
mgkg
extract
echinacea
purpurea
ep
hypericum
perforatum
hp
eleutherococcu
senticosu
es
drug
day
di
carlo
et
al
treatment
abl
modifi
prolactin
serum
level
wherea
treatment
ep
hp
higher
dose
signifi
cantli
inhibit
prolactin
product
prolactin
report
play
import
role
immun
system
regul
treatment
es
ineffect
suggest
possibl
mechan
effect
could
echinacea
purpurea
hypericum
perforatum
extract
display
direct
dopaminerg
activ
although
involv
gabaerg
system
could
exclud
yearandahalf
old
dri
echinacea
root
found
retain
cytokinemodul
capabl
invitro
human
older
adult
model
infl
uenza
vaccin
senchina
et
al
model
peripher
blood
mononuclear
cell
collect
subject
month
postvaccin
stimul
vitro
two
type
infl
uenza
virus
contain
trival
vaccin
alcohol
tinctur
prepar
root
one
seven
echinacea
speci
e
angustifolia
e
pallida
e
paradoxa
e
purpurea
e
sanguinea
e
simulata
e
tennesseensi
four
speci
e
angustifolia
e
purpurea
e
simulata
e
tennesseensi
augment
interleukin
product
diminish
product
effect
interferon
ifngamma
product
parnham
report
squeez
sap
e
purpurea
wide
use
selfmed
well
toler
longterm
oral
administr
advers
event
healthi
adult
contrast
parenter
administr
squeez
sap
e
purpurea
may
associ
symptom
immunostimul
shiver
fever
muscl
weak
littl
effect
lymphocyt
respons
report
caus
transient
lymphopenia
patient
infect
variou
etiolog
doubleblind
placebocontrol
crossov
design
studi
two
treatment
period
day
involv
healthi
male
volunt
age
rang
year
oral
administr
echinacea
purpurea
press
juic
week
minor
effect
two
lymphocyt
subpopul
determin
studi
schwarz
et
al
small
differ
observ
number
lymphocyt
natur
killer
cell
question
physiolog
relev
echinacea
purpurea
found
immunomodulatori
properti
ritchi
et
al
found
subgroup
volunt
show
low
pretreat
level
cytokin
n
show
signifi
cant
stimul
factor
upon
treatment
e
purpurea
increas
wherea
level
subject
higher
pretreat
level
remain
unaffect
volunt
report
high
stress
level
n
cold
per
year
experienc
signifi
cant
transient
increas
interferon
upon
treatment
subject
low
cortisol
level
n
show
signifi
cant
downregul
acutephas
protein
interleukin
rang
subject
higher
cortisol
level
show
downregul
author
conclud
thu
regul
product
chemokin
cytokin
accord
current
immun
statu
respons
exogen
stimuli
suscept
viral
infect
exposur
stress
review
immunomodulatori
effi
caci
prepar
contain
extract
echinacea
control
clinic
trial
random
doubl
blind
identifi
ed
melchart
et
al
studi
indic
prepar
contain
extract
echinacea
could
effi
caciou
immunomodul
howev
present
evid
still
insuffi
cient
clear
therapeut
recommend
prepar
use
dose
employ
specifi
c
indic
root
e
purpurea
found
induc
substanc
show
interferonlik
activ
skwarek
et
al
biolog
activ
studi
show
protect
titr
largest
dilut
protect
cell
viru
infect
interferonlik
materi
echinacea
purpurea
panax
ginseng
extract
concentr
respect
signifi
cantli
enhanc
natur
killer
cell
function
human
erythromyeloblastoid
leukaemia
cell
line
cell
healthi
subject
chronic
fatigu
syndrom
acquir
immunodefi
cienci
syndrom
aid
patient
see
et
al
similarli
addit
either
herb
signifi
cantli
increas
antibodydepend
cellular
cytotox
adcc
human
herpesviru
infect
cell
peripher
blood
mononuclear
cell
pbmc
subject
group
thu
extract
echinacea
purpurea
panax
ginseng
enhanc
cellular
immun
function
pbmc
normal
individu
patient
depress
cellular
immun
extract
taxa
genu
echinacea
found
antivir
activ
herp
simplex
hsv
viru
type
vitro
expos
visibl
uva
light
binn
et
al
n
hexan
extract
root
contain
alken
amid
activ
gener
ethyl
acet
extract
contain
caffeic
acid
echinacea
purpurea
n
hexan
root
extract
mic
mgml
one
potent
inhibitor
hsv
aqueou
extract
e
purpurea
root
contain
rel
potent
activ
herp
simplex
viru
hsv
infl
uenza
viru
fv
rhinoviru
rv
fraction
low
amount
caffeic
acid
alkamid
ethyl
acet
fraction
contain
signifi
cant
weak
activ
hsv
fv
contain
signifi
cant
level
cichor
acid
aqueou
fraction
e
purpurea
aerial
part
contain
potent
activ
herp
simplex
viru
infl
uenza
viru
antivir
activ
could
partli
attribut
polysaccharid
cichor
acid
compon
individu
contribut
could
account
total
antivir
activ
addit
ethanoland
ethyl
acetatesolubl
fraction
leav
stem
contain
uncharacter
potent
antivir
photosensit
absent
fl
ower
extract
none
fraction
howev
contain
antirhinoviru
studi
show
exposur
cultur
line
human
bronchial
epitheli
cell
rhinoviru
infect
stimul
releas
least
cytokinerel
molecul
includ
sever
import
chemokin
known
attract
infl
ammatori
cell
effect
revers
simultan
exposur
either
two
echinacea
extract
sharma
et
al
rhinoviru
infect
cell
line
result
dramat
increas
multipl
transcript
factor
includ
proinfl
ammatori
factor
examin
nfkb
stat
sharma
et
al
howev
rhinovirusinfect
cell
treat
either
two
echinacea
extract
transcript
factor
level
reduc
low
level
although
pattern
reduct
differ
two
extract
result
could
help
explain
benefi
cial
effect
echinacea
consumpt
virus
test
rhinovirus
infl
uenza
viru
respiratori
syncyti
viru
adenoviru
type
herp
simplex
viru
type
induc
substanti
secret
addit
sever
chemokin
line
human
bronchial
epitheli
cell
sharma
et
al
everi
case
howev
echinacea
echinaforc
ethanol
extract
herb
root
e
purpurea
inhibit
induct
echinacea
prepar
also
show
potent
virucid
activ
virus
membran
indic
multifunct
potenti
herb
result
support
concept
certain
echinacea
prepar
could
allevi
cold
fl
u
symptom
possibl
respiratori
disord
inhibit
viral
growth
secret
proinfl
ammatori
cytokin
separ
invitro
studi
human
iv
highli
pathogen
avian
iv
hpaiv
well
swine
origin
iv
soiv
inactiv
cell
cultur
assay
echinacea
purpurea
ef
prepar
concentr
rang
recommend
dose
oral
consumpt
sever
order
lower
magnitud
pleschka
et
al
detail
studi
hpaiv
strain
indic
direct
contact
ef
viru
requir
prior
infect
order
obtain
maximum
inhibit
viru
replic
hemagglutin
assay
show
extract
inhibit
receptorbind
activ
viru
suggest
extract
interfer
viral
entri
cell
recent
studi
report
standard
extract
echinacea
purpurea
exhibit
immunomodul
broad
antivir
effect
respiratori
tract
virus
schapow
haemagglutinin
neuraminidas
block
contrast
oseltamivir
resist
caus
random
doubleblind
placebocontrol
studi
month
confi
rmed
support
immun
resist
act
directli
seri
virus
report
effi
caciou
safe
respiratori
tract
infect
longterm
shortterm
prevent
well
acut
treatment
openlabel
fi
xedsequ
studi
hivinfect
patient
show
coadministr
e
purpurea
root
extract
contain
capsul
etravirin
nonnucleosid
revers
transcriptas
inhibitor
hiv
safe
well
toler
hivinfect
patient
et
al
geometr
mean
ratio
etravirin
coadminist
e
purpurea
rel
etravirin
alon
maximum
concentr
area
concentrationtim
curv
hour
concentr
end
dose
interv
data
suggest
dose
adjust
etravirin
necessari
rhinovirus
infl
uenza
virus
herp
virus
calcivru
found
suscept
e
purpurea
ethanol
extract
aqueou
extract
respiratori
syncyti
viru
coronaviru
mous
suscept
e
purpurea
ethanol
extract
polio
viru
suscept
extract
vimalanathan
et
al
pleschka
et
al
hudson
standard
echinacea
extract
echinaforc
found
dual
action
sever
import
respiratori
bacteria
kill
effect
antiinfl
ammatori
effect
readili
inactiv
streptococcu
pyogen
often
associ
sore
throat
sever
pulmonari
infect
haemophilu
infl
uenza
legionella
pneumophila
revers
proinfl
ammatori
respons
staphylococcu
aureu
methicillinresist
sensit
strain
mycobacterium
smegmati
less
sensit
bactericid
effect
echinacea
howev
proinfl
ammatori
respons
still
complet
revers
contrast
pathogen
test
includ
candida
albican
rel
resist
result
support
concept
use
standard
echinacea
prepar
control
symptom
associ
bacteri
respiratori
infect
alkylamid
z
e
acid
isobutylamid
e
e
z
e
z
tetraeno
acid
isobutylamid
e
e
dienoic
acid
isobutylamid
e
acid
isobutylamid
e
purpurea
suppress
product
raw
macrophagelik
cell
infect
infl
uenza
strain
e
edieno
acid
isobutylamid
especi
effect
inhibit
product
mediat
also
strongli
inhibit
product
gcsf
rant
contrast
ethanol
extract
prepar
e
purpurea
dormant
root
display
rang
effect
suppress
stimul
mediat
product
analysi
extract
reveal
slight
variat
concentr
alkylamid
caftar
acid
cichor
acid
activ
extract
strongli
correl
concentr
compound
invitro
studi
suggest
e
purpurea
extract
potenti
use
allevi
symptom
patholog
associ
infect
infl
uenza
herbal
prepar
includ
echinacea
purpurea
report
improv
cold
symptom
adult
ineffect
children
fashner
et
al
randolph
et
al
found
overal
gene
express
pattern
hour
day
take
echinacea
product
cold
fl
u
six
healthi
nonsmok
subject
year
age
consist
antiinfl
ammatori
respons
express
beta
tumour
necrosi
factoralpha
intracellular
adhes
molecul
modestli
decreas
day
return
baselin
day
express
interferonalpha
steadili
rose
day
consist
antivir
respons
data
present
gene
express
respons
pattern
consist
echinacea
report
abil
reduc
durat
intens
cold
fl
u
symptom
mix
result
obtain
clinic
studi
effi
caci
e
purpurea
combat
respiratori
tract
infect
random
doubleblind
placebocontrol
studi
recruit
healthi
adult
volunt
contract
common
cold
took
time
daili
tablet
either
echinacea
purpurea
prepar
herba
radix
echinacea
purpurea
concentr
prepar
time
higher
concentr
special
echinacea
purpurea
radix
prepar
total
differ
placebo
felt
healthi
longer
day
brinkeborn
et
al
found
concentr
prepar
signifi
cantli
effect
special
echinacea
extract
placebo
treatment
well
toler
among
echinacea
group
frequenc
advers
event
signifi
cantli
higher
placebo
group
conclud
echinacea
concentr
well
repres
lowrisk
effect
altern
standard
symptomat
medicin
acut
treatment
common
cold
random
doubleblind
placebocontrol
trial
subject
age
year
total
subject
contract
common
cold
echinacea
placebo
goel
et
al
total
daili
symptom
score
found
lower
echinacea
group
placebo
follow
element
studi
protocol
throughout
treatment
period
respons
rate
treatment
greater
echinacea
group
advers
event
profi
le
observ
group
research
conclud
earli
intervent
standard
formul
echinacea
result
reduc
symptom
sever
subject
natur
acquir
upper
respiratori
tract
infect
clinic
studi
echinilin
formul
prepar
freshli
harvest
echinacea
purpurea
plant
standard
basi
three
known
activ
compon
alkamid
cichor
acid
polysaccharid
placebo
administ
volunt
onset
cold
period
day
eight
dose
mldose
day
three
dose
subsequ
day
goel
et
al
decreas
total
daili
symptomat
score
evid
echinacea
group
placebo
group
effect
echinacea
associ
signifi
cant
sustain
increas
number
circul
total
white
blood
cell
monocyt
neutrophil
natur
killer
cell
later
part
cold
echinacea
treatment
suppress
coldrel
increas
superoxid
product
neutrophil
result
suggest
echinilin
enhanc
nonspecifi
c
immun
respons
elicit
free
radic
scaveng
properti
may
led
faster
resolut
cold
symptom
jawad
et
al
conduct
random
doubleblind
placebocontrol
trial
investig
safeti
risk
effi
caci
benefi
echinacea
purpurea
herba
root
extract
prevent
common
cold
episod
healthi
subject
echinacea
extract
found
reduc
total
number
cold
episod
cumul
episod
day
within
group
painkillermed
episod
echinacea
inhibit
viral
confi
rmed
cold
especi
prevent
envelop
viru
infect
echinacea
show
maxim
effect
recurr
infect
prevent
effect
increas
therapi
complianc
adher
protocol
total
advers
event
occur
echinacea
placebo
treatment
nine
particip
experienc
advers
event
least
possibl
relat
studi
drug
advers
drug
reaction
thu
safeti
echinacea
noninferior
placebo
studi
conclud
compliant
prophylact
intak
e
purpurea
period
appear
provid
posit
risk
benefi
ratio
random
placebocontrol
doubleblind
studi
treatment
fl
uid
extract
echinacea
purpurea
wide
use
prevent
treatment
cold
respiratori
infect
signifi
cantli
decreas
incid
durat
sever
cold
respiratori
infect
compar
placebo
grimm
treatment
period
patient
echinacea
group
patient
placebo
group
least
one
cold
respiratori
infect
averag
number
cold
respiratori
infect
per
patient
echinacea
group
placebo
group
signifi
cant
differ
treatment
group
number
infect
categori
sever
side
effect
observ
patient
echinacea
group
seven
patient
placebo
group
random
doubleblind
placebocontrol
trial
adult
travel
back
australia
america
europ
africa
period
week
commerci
fl
ight
via
economi
class
supplement
standard
echinacea
tablet
taken
travel
may
prevent
effect
develop
respiratori
symptom
travel
involv
longhaul
fl
ight
tiralongo
et
al
anoth
studi
patient
enrol
within
hour
cold
symptom
onset
random
doubleblind
placebocontrol
design
wherein
patient
receiv
either
mg
e
purpurea
freezedri
press
juic
aerial
portion
plant
lactos
placebo
time
daili
cold
symptom
reliev
end
day
whichev
came
fi
rst
yale
liu
statist
signifi
cant
differ
observ
treatment
group
either
total
symptom
score
mean
individu
symptom
score
time
resolut
symptom
statist
differ
effi
caci
e
purpurea
reduc
common
cold
confi
rmed
multicent
random
placebo
control
trial
echinacea
purpurea
found
ineffect
treat
upper
respiratori
tract
infect
children
age
year
mainou
signifi
cant
differ
durat
sever
symptom
echinacea
purpurea
compar
placebo
children
upper
respiratori
tract
infect
anoth
random
doubleblind
placebocontrol
trial
children
age
year
includ
upper
respiratori
tract
infect
uri
treat
echinacea
placebo
echinacea
purpurea
found
effect
treat
uri
symptom
children
use
associ
increas
risk
rash
taylor
et
al
scoop
et
al
conduct
metaanalysi
therapeut
effect
echinacea
treatment
prevent
cold
wherein
suitabl
studi
select
pool
data
exclud
analysi
relat
studi
spontan
common
cold
metaanalysi
suggest
standard
extract
echinacea
effect
prevent
symptom
common
cold
clinic
inocul
compar
placebo
howev
prospect
appropri
structur
clinic
studi
requir
confi
rm
although
echinacea
prepar
test
clinic
trial
differ
greatli
evid
prepar
base
aerial
part
echinacea
purpurea
might
effect
earli
treatment
cold
adult
result
fulli
consist
lind
et
al
benefi
cial
effect
echinacea
prepar
prevent
purpos
might
exist
shown
independ
replic
rigor
random
trial
metaanalysi
studi
provid
publish
evid
support
echinacea
benefi
decreas
incid
durat
common
cold
shah
et
al
woelkart
et
al
state
echinacea
prepar
effect
treatment
effect
placebo
similarli
effect
treatment
prevent
treatment
common
cold
recent
review
effi
caci
echinacea
cold
prevent
hart
dey
reiter
view
residu
uncertainti
gap
evid
way
summar
webpag
may
prove
diffi
cult
consum
assimil
evid
well
undertak
highqual
trial
complementari
medicin
need
ensur
precis
report
uncertainti
echinacea
includ
e
purpurea
found
phototox
antimicrobi
activ
fungi
includ
clinic
relev
pathogen
fungi
result
show
hexan
extract
echinacea
variabl
inhibit
growth
yeast
strain
saccharomyc
cerevisia
candida
shehata
c
kefyr
c
albican
c
steatulytica
c
tropicali
near
uv
irradi
phototox
lower
extent
without
irradi
convent
antifung
activ
binn
et
al
presenc
polyacetylen
alkylamid
extract
differ
organ
confi
rmed
echinacea
purpurea
relat
phototox
activ
signific
phototox
demonstr
pure
e
purpurea
root
minor
phototox
induc
two
e
purpurea
acetylen
compound
e
z
acid
isobutylamid
e
e
z
e
ztetraeno
acid
isobutylamid
phototox
activ
echinacea
spp
primarili
attribut
ketoalken
ketoalkyn
abundantli
present
root
root
extract
eight
echinacea
speci
includ
e
purpurea
show
antifung
activ
pathogen
fungi
trichophyton
tonsuran
mentagrophyt
microsporum
gypseum
pseudallescheria
boydii
cryptococcu
neoforman
two
candida
albican
isol
merali
et
al
recent
studi
echinacea
purpurea
reveal
certain
standard
prepar
contain
potent
select
antivir
antimicrobi
activ
hudson
addit
display
multipl
immunomodulatori
activ
compris
stimul
certain
immun
function
phagocyt
activ
macrophag
suppress
proinfl
ammatori
respons
epitheli
cell
virus
bacteria
manifest
alter
secret
variou
cytokin
chemokin
e
purpurea
dri
aerial
part
ethanol
extract
show
consider
growth
inhibit
candida
albican
saccharomyc
cerevisia
growth
inhibit
zone
observ
aspergillu
niger
et
al
invitro
studi
show
standard
prepar
echinacea
purpurea
could
provid
safe
twofold
benefi
acn
individu
inhibit
prolifer
gramposit
bacterium
propionibacterium
acn
revers
bacterialinduc
infl
ammat
sharma
et
al
e
purpurea
complet
revers
bacteri
increas
secret
substanti
amount
sever
proinfl
ammatori
cytokin
includ
brought
cytokin
level
back
normal
root
extract
three
commerci
speci
echinacea
e
purpurea
e
pallida
var
angustifolia
e
pallida
var
pallida
inhibit
enzym
merali
et
al
result
show
echinacea
spp
signifi
cant
antiinfl
ammatori
activ
alcohol
extract
echinacea
angustifolia
echinacea
pallida
echinacea
purpurea
signifi
cantli
inhibit
product
lipopolysaccharid
lp
activ
raw
macrophag
cell
line
zhai
et
al
arginas
activ
raw
cell
stimul
signifi
cantli
increas
alcohol
extract
three
echinacea
speci
polar
fraction
contain
caffeic
acid
deriv
enhanc
arginas
activ
lipophil
fraction
contain
alkamid
exhibit
potenti
inhibit
product
ino
express
result
suggest
antiinfl
ammatori
activ
echinac
might
due
multipl
activ
metabolit
work
togeth
switch
macrophag
activ
classic
activ
toward
altern
activ
gml
sever
e
purpurea
alkamid
isol
e
purpurea
root
inhibit
cyclooxygenas
coxi
coxii
enzym
rang
respect
compar
control
clifford
et
al
chicca
et
al
demonstr
ethanol
e
purpurea
radix
herba
extract
elicit
synergist
pharmacolog
effect
endocannabinoid
system
vitro
supraaddit
action
n
alkylamid
combin
observ
level
intracellular
calcium
releas
function
cannabinoid
receptor
cb
activ
likewis
synerg
radix
herba
tinctur
observ
lpsstimul
cytokin
express
human
pbmc
express
antiinfl
ammatori
cytokin
signifi
cantli
superstimul
express
proinfl
ammatori
protein
inhibit
strongli
upon
combin
extract
conclud
n
alkylamid
extract
act
concert
exert
pleiotrop
effect
modul
endocannabinoid
system
simultan
target
cb
receptor
endocannabinoid
transport
degrad
cannabinoid
cb
cb
receptor
belong
famili
g
proteincoupl
receptor
primari
target
endogen
cannabinoid
n
arachidonoyl
ethanolamin
glycerol
cb
receptor
believ
play
import
role
distinct
pathophysiolog
process
includ
metabol
dysregul
infl
ammat
pain
bone
loss
mitogeninduc
murin
skin
infl
ammat
studi
suggest
alkamid
activ
antiinfl
ammatori
compon
present
echinac
plant
hou
et
al
mix
alkamid
major
compon
e
e
z
z
e
tetraeno
acid
isobutylamid
isol
e
purpurea
root
extract
bioactiv
elucid
macrophag
alkamid
signifi
cantli
inhibit
cyclooxygenas
activ
lipopolysaccharideinduc
express
induc
nitric
oxid
synthas
specifi
c
cytokin
chemokin
ie
interleukin
il
elev
heme
protein
express
cichor
acid
howev
exhibit
littl
effect
anoth
studi
three
alkamid
nitidanin
diisovalerian
identifi
ed
togeth
known
alkamid
one
sesquiterpen
root
echinacea
purpurea
hohmann
et
al
interact
gproteincoupl
cannabinoid
receptor
examin
rat
brain
membran
prepar
partial
invers
agonist
compound
cannabinoid
receptor
identifi
ed
among
metabolit
character
weak
moder
interact
gprotein
signal
mechan
upon
coadministr
number
prove
capabl
inhibit
stimul
pure
agonist
therebi
demonstr
cannabinoid
receptor
antagonist
properti
earlier
studi
alkylamid
anandamid
found
potent
inhibit
lipopolysaccharideinduc
infl
ammat
human
whole
blood
exert
modulatori
effect
cytokin
express
effect
exclus
relat
cb
bind
alkylamid
e
e
z
z
tetraeno
acid
isobutylamid
e
e
dienoic
acid
isobutylamid
bound
cb
receptor
strongli
endogen
cannabinoid
anandamid
antagonist
ki
nm
also
noncb
bind
alkylamid
e
acid
isobutylamid
signifi
cantli
inhibit
lipopolysaccharideinduc
tumour
necrosi
factor
alpha
express
nm
cb
independ
manner
anim
studi
found
dietari
administr
e
purpurea
prepar
signifi
cantli
decreas
prostat
weight
rat
increas
lymphocyt
number
week
skaudicka
et
al
echinacea
purpurea
root
hexan
extract
reduc
cell
viabil
human
pancreat
cancer
mia
colon
cancer
cell
line
concentrationand
timedepend
vitro
chicca
et
al
e
purpurea
fl
ower
extract
cichor
acid
signifi
cantli
inhibit
prolifer
doseand
timedepend
manner
human
colon
cancer
cell
tsai
et
al
cichor
acid
treatment
decreas
telomeras
activ
cell
cichor
acid
effect
induc
apoptosi
colon
cancer
cell
character
dna
fragment
activ
cleavag
parp
downregul
studi
found
e
purpurea
could
stimul
immun
system
mice
levamisol
better
prophylact
effect
teratogen
effect
phenytoin
evidenc
lower
incid
phenytoininduc
cleft
palat
signifi
cant
mahabadi
et
al
cleft
palat
incid
fetus
mice
receiv
phenytoin
phenytoin
levamisol
phenytoin
echinacea
extract
respect
mean
weight
length
fetus
anim
receiv
levamisol
echinacea
extract
signifi
cantli
greater
receiv
phenytoin
studi
show
e
e
z
z
e
tetraeno
acid
isobutylamid
isol
echinacea
purpurea
root
dosedepend
induc
heme
oxygenas
ho
protein
express
lipopolysaccharidestimul
murin
macrophag
like
regul
jnkmediat
pathway
increas
sapkjnk
phosphoryl
cjun
protein
express
phosphoryl
transcript
factor
bind
consensu
dna
activ
hou
et
al
markedli
induc
cjun
protein
express
suppress
serum
aminotransferas
activ
express
hepatocyt
damag
liver
tissu
lipopolysaccharid
galactosamin
treat
mice
result
suggest
potenti
applic
echinacea
topsel
herbal
supplement
hepatoprotect
agent
ethanol
fl
ower
extract
show
toxic
mutagen
toward
salmonella
typhimurium
without
mix
tsai
et
al
ethanol
extract
mgplate
exhibit
dosedepend
inhibitori
effect
mutagen
conclud
freezedri
e
purpurea
fl
ower
ethanol
extract
exhibit
good
antioxid
antimutagen
activ
e
purpurea
administr
signifi
cantli
amelior
detriment
reduct
effect
gamma
ray
peripher
blood
haemoglobin
level
red
blood
cell
differenti
white
blood
cell
bone
marrow
cell
antioxid
activ
mice
abouelella
et
al
radioprotect
effect
similar
radio
recoveri
cur
comparison
control
group
test
paramet
radioprotect
effi
cienci
greater
radio
recoveri
haemoglobin
level
fi
rst
week
lymphoid
cell
count
thiobarbitur
acidreact
substanc
tbar
level
fourth
week
superoxid
dismutas
sod
activ
fi
rst
week
compar
level
paramet
control
group
purpl
conefl
ower
tinctur
found
improv
work
capac
endur
characterist
white
male
mice
convent
forc
swim
test
kurkin
et
al
actoprotect
effect
attribut
phenylpropanoid
echinacosid
doubleblind
design
placebocontrol
selfadminist
studi
men
year
week
oral
echinacea
supplement
result
signifi
cant
increas
erythropoietin
epo
maxim
oxygen
uptak
run
economi
compar
placebo
whitehead
et
al
cichor
acid
extract
e
purpurea
fl
ower
found
signifi
cant
tyrosinas
inhibit
activ
broad
rang
concentr
mgml
jiang
et
al
variou
echinacea
extract
could
inhibit
prolifer
three
speci
trypanosomatid
leishmania
donovani
leishmania
major
trypanosoma
brucei
canla
et
al
standard
ethanol
extract
e
purpurea
l
moench
revers
proinfl
ammatori
activ
product
cytokin
leishmania
donovani
human
bronchial
epitheli
cell
human
skin
fi
broblast
sever
alkamid
isol
e
purpurea
root
exhibit
mosquitocid
activ
caus
mortal
aed
aegypti
larva
clifford
et
al
studi
show
echinacea
alkylamid
degrad
timeand
nadphdepend
manner
microsom
fraction
suggest
metabol
cytochrom
enzym
human
liver
matthia
et
al
differ
suscept
pure
synthet
alkylamid
microsom
degrad
e
n
isobutylundeca
metabol
tenth
extent
e
e
z
z
n
ident
incub
condit
alkylamid
metabolit
detect
found
predict
epoxid
hydroxyl
dealkyl
product
fi
nding
suggest
echinacea
may
affect
metabol
concurr
ingest
pharmaceut
cytochrom
enzym
appear
princip
system
respons
metabol
echinacea
compon
main
hepat
extrahepat
isoform
appear
involv
toselli
et
al
epoxid
format
ndealkyl
hydroxyl
report
main
metabol
pathway
mediat
interact
determin
circul
concentr
durat
action
phytochem
well
potenti
interact
chemic
invivo
studi
rat
show
e
purpurea
may
interact
cytochrom
enzym
induc
signifi
cant
herbdrug
interact
may
alter
pharmacotherapi
mrozikiewicz
et
al
echinacea
ethanol
extract
could
potent
inhibit
express
mrna
weaker
inhibitori
effect
observ
long
applic
echinacea
ethanol
extract
activ
also
inhibit
extract
lesser
degre
activ
fi
nding
suggest
echinacea
extract
may
infl
uenc
metabol
differ
drug
may
initi
chemic
carcinogenesi
activ
compound
carcinogen
metabolit
multiherb
product
sambucu
forc
contain
echinacea
purpurea
sambucu
nigra
main
constitu
found
inhibit
activ
ic
valu
et
al
inhibitori
potenc
appear
exclus
exert
e
purpurea
implic
insignifi
cant
inhibit
nigra
echinacea
purpurea
act
differ
multiherb
product
show
dual
inhibit
profi
le
uncompetit
substratedepend
inhibit
timedepend
substrateindepend
inhibitori
mechan
mechanist
differ
suggest
caus
herbherb
interact
multiherb
product
woman
atopi
experienc
anaphylaxi
take
commerci
extract
echinacea
hypersensit
confi
rmed
skin
prick
rast
test
mullin
regular
ingest
echinacea
survey
patient
atopi
combin
detect
echinacea
bind
ige
atop
subject
skin
test
moder
strong
reactiv
rast
test
indic
possibl
sever
allerg
reaction
even
fi
rsttime
use
due
crossreact
structur
similar
allergen
accord
review
huntley
et
al
despit
volumin
data
avail
effi
caci
echinacea
echinacea
spp
name
e
angustifolia
e
pallida
e
purpurea
safeti
issu
monitor
advers
event
focus
shortterm
use
echinacea
report
associ
rel
good
safeti
profi
le
slight
risk
transient
revers
advers
event
major
advers
event
report
echinacea
product
allerg
reaction
rang
contact
dermat
anaphylaxi
mahadi
et
al
patient
allergi
plant
daisi
famili
asteracea
instruct
use
product
contain
echinacea
use
echinacea
product
pregnanc
lactat
would
appear
illadvis
light
pauciti
data
area
accord
review
perri
et
al
good
scientifi
c
evid
prospect
cohort
studi
oral
consumpt
echinacea
fi
rst
trimest
increas
risk
major
malform
lowlevel
evid
base
expert
opinion
show
oral
consumpt
echinacea
recommend
dose
safe
use
pregnanc
lactat
echinacea
nonteratogen
use
pregnanc
howev
qualiti
studi
need
determin
safeti
week
oral
administr
express
juic
e
purpurea
dose
amount
mani
time
human
therapeut
dose
laboratori
test
necropsi
fi
nding
present
evid
toxic
effect
rat
meng
et
al
test
mutagen
carri
microorgan
mammalian
cell
invitro
mice
gave
neg
result
invitro
carcinogen
studi
e
purpurea
produc
malign
transform
hamster
embryo
cell
studi
show
alkylamid
echinacea
speci
readili
transport
across
monolay
indic
transport
across
intestin
barrier
may
contribut
invivo
effect
echinacea
prepar
jager
et
al
matthia
et
al
caffeic
acid
conjug
matthia
et
al
studi
nine
healthi
volunt
found
alkamid
rapidli
absorb
measur
plasma
minut
echinacea
e
purpurea
e
angustifolia
tablet
ingest
standard
highfat
breakfast
remain
detect
hour
matthia
et
al
maxim
concentr
sum
alkamid
human
plasma
reach
within
hour
post
ingest
averag
ng
eqml
plasma
obviou
differ
observ
pharmacokinet
individu
total
alkamid
caffeic
acid
conjug
could
identifi
ed
plasma
sampl
time
tablet
ingest
alkamid
e
e
z
e
z
tetraeno
acid
isobutylamid
found
rapidli
absorb
measur
plasma
minut
administr
mg
echinacea
purpurea
phytotherapeut
lozeng
remain
detect
hour
mg
lozeng
hour
mg
lozeng
mg
lozeng
measur
minut
administr
remain
detect
hour
administr
guiotto
et
al
signifi
cant
doseindepend
downregul
proinfl
ammatori
cytokin
tnf
observ
hour
result
demonstr
pharmacokinet
e
e
z
e
z
tetraeno
isobutylamid
linear
absorpt
rapid
minut
appar
lag
time
thu
indic
possibl
fraction
drug
absorb
oral
mucosa
earlier
studi
oral
ingest
arithmet
mean
c
max
e
e
z
e
z
tetraeno
acid
isobutylamid
absorb
echinacea
purpurea
tinctur
ngml
serum
minut
max
echinacea
tablet
max
tablet
minut
c
max
ngml
woelkart
et
al
e
purpurea
prepar
led
effect
immun
system
accord
concentr
proinfl
ammatori
cytokin
tnfalpha
twentythre
hour
oral
applic
signifi
cant
downregul
tnfalpha
lp
prestimul
whole
blood
found
howev
signifi
cant
chang
concentr
observ
alkylamid
acid
isobutylamid
constitu
e
purpurea
goel
et
al
e
e
z
e
ztetraeno
acid
isobutylamid
dtai
abund
alkylamid
e
purpurea
success
quantifi
ed
patient
plasma
ingest
e
purpurea
extract
lcmsm
assay
goey
et
al
echinacea
spp
nativ
north
america
tradit
use
indian
tribe
varieti
ailment
includ
mouth
sore
cold
snakebit
kindscher
tradit
use
e
purpurea
e
angustifolia
e
pallida
includ
follow
respiratori
infect
cold
fl
u
bronchiti
strep
throat
toothach
urinari
tract
infect
herp
sore
gonorrhoea
skin
disord
staph
infect
cold
sore
ulcer
wound
burn
insect
bite
eczema
allergi
other
rheumatoid
arthriti
hudson
dri
echinacea
purpurea
ep
use
feed
addit
improv
meat
qualiti
oxid
statu
arbor
acr
broiler
lee
et
al
addit
ep
signifi
cantli
increas
waterhold
capac
decreas
storag
loss
breast
thigh
fi
llet
day
old
result
trolox
equival
antioxid
capac
catalas
superoxid
dismutas
signifi
cantli
higher
ep
supplement
group
control
group
serum
liver
spleen
tissu
result
show
antioxid
enzym
activ
higher
ep
powder
day
age
studi
show
e
purpurea
potenti
immunostimulatori
feed
addit
newcastl
diseas
viru
lay
hen
fatten
pig
intermitt
applic
et
al
perform
lay
hen
impact
feed
addit
applic
press
e
purpurea
aerial
part
juic
ethanol
ferment
juic
signifi
cant
chang
found
number
lymphocyt
phagocytosi
rate
newcastl
diseas
viru
ndv
antibodi
titr
number
lymphocyt
highest
group
receiv
ethanol
juic
fi
consecut
day
phagocytosi
reduc
group
provid
ethanol
juic
day
highest
ndv
antibodi
titr
seen
group
receiv
ferment
juic
day
addit
phagocytosi
granulocyt
determin
fatten
pig
kg
day
echinacea
applic
ethanol
ferment
juic
signifi
cant
increas
found
echinacea
formul
number
lymphocyt
also
increas
signifi
cantli
group
provid
echinacea
purpl
conefl
ower
easili
propag
either
seed
veget
divis
root
cut
basal
cut
bloom
throughout
spring
summer
pollin
butterfl
i
bee
